Trial intelligence / Profile preview

PPF vs Crystalloids in Major Liver Resection

NCT05033704Unknown

Sponsor
Hamad Medical Corporation
Start
Sep 2019
Primary completion
Sep 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of plasma protein fraction human in fluid and electrolyte disorders (2 arms), sponsored by Hamad Medical Corporation. Primary endpoints: Base deficit, Strong Ion Difference and 1 more. Status: unknown.

02

Drugs

plasma protein fraction human
03

Conditions

fluid and electrolyte disorders

Beyond the preview

Go deeper on NCT05033704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05033704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call